Molecular Diagnostics Market : Industry Future Set To Massive Growth With High CAGR Value By 2032

 The global molecular diagnostics market is expected to see a CAGR of 18% for forecast period (2022-2032)

As per Future Market Insights’ latest industry analysis, as per a recent market analysis by Future Market Insights (FMI), global molecular diagnostics market is anticipated to showcase an opulent growth opportunity over the projection period by exhibiting a CAGR of 18% from 2022 to 2032. At present, the market is valued at around US$ 14802.156 Million in 2022 and is anticipated to reach a high of US$ 59882.97671 Million by the year 2032. According to Future Market Insights' historical analysis, the global molecular diagnostics market exhibited a CAGR of 15%.

An inevitable surge in the demand for molecular diagnostics has been witnessed over the past few years and the market is expected to accelerate at a steady pace attributed to its heavy usage within the process of manufacturing a wide range of specialty products like advanced polymers, sealants, additives, specialty paints, pigments, coatings, and more.

A substantial upsurge has been observed in the demand for the molecular diagnostics market in recent years. The global market is expected to progress at a healthy pace attributed to the rising prevalence of infectious diseases and several variants of cancer worldwide. Furthermore, the rising awareness and acceptance of personalized medical doses and increasing biomarker identification are anticipated to help the market development over the assessment period.

Key Takeaways

  • The demand for molecular diagnostics is anticipated to surge over the forecast period attributing to the increasing adoption of molecular diagnostics in emerging markets, therefore offering lucrative growth opportunities for the molecular diagnostics market.
  • In addition to that, several factors including increasing demand for reagents, rising adoption of point-of-care testing, and advancement in Research and Development activities in the biotechnology and pharmaceutical industry, are expected to propel the market development over the forecast period.
  • The global market is further to have a great positive impact owing to the growing number of patients suffering from infectious diseases and lethal cancers among other diseases that require molecular analysis for diagnosis purposes and for early commencement of the treatment.
  • In addition to that, the advancements in healthcare infrastructure and expansion of new technologies in medicine have helped to cater to the growing patient pool and are predicted to further the market growth of molecular diagnostics.
  • The molecular diagnostics market is witnessing the emergence of various new market players offering advanced diagnostic solutions with faster, better, and cost-efficient molecular diagnostics. The emergence of such companies is predicted to bolster the progress of the molecular diagnostics market over the forecast period. The strategic measures taken by these companies are predicted to strengthen their foothold and result in market expansion in various untapped regions.

Get a Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1262

 Competitive Landscape

The prominent market players are proliferating in the forum and concentrating on introducing new products and constantly focusing on improving their product offerings in order to cater to the changing consumer needs efficiently while simultaneously restraining their competitiveness globally.

Keen attention is paid by the key market players to the maintenance and quality of products and innovation. Such prominent market players are also focusing on diversifying their range of manufacturing by indulging in mergers and acquisitions and adopting organic growth strategies for a strong foothold in the global market.

Some of the key companies in the market are:

  • ABBOTT LABORATORIES
  • Agilent Technologies Inc.
  • BECTON DICKINSON AND COMPANY
  • BIOMERIEUX SA
  • DANAHER CORPORATION
  • F. HOFFMAN LA-ROCHE LTD.
  • GRIFOLS S.A.
  • HOLOGIC INC.
  • QIAGEN INC.
  • SIEMENS AG (SIEMENS HEALTHINEERS)

More Insights into the Molecular Diagnostics Market

North America is expected to witness excellent growth over the forecast period attributed to the favorable reimbursement scenario in this region which is expected to fuel growth in the market. Furthermore, the surging healthcare expenditure in the North American region is anticipated to bolster growth in the North American molecular diagnostics market.

Europe is another market showcasing lucrative growth opportunities in the molecular diagnostics market. The growth is attributed to the rising prevalence of infectious diseases and cancer in the region which is aiding the growth of molecular diagnostics in the European regions.

In addition to that, European regional growth can also be ascribed to the surging use of POC diagnostic tests, and increased awareness of the early diagnosis of diseases in emerging countries is yet another factor to drive the market growth in the region.

Key Segments in The Molecular Diagnostics Market

By Product and Service:

  • Reagents and Kits
  • Instruments
  • Service and Software

By Technology:

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INNAT)
  • DNA Sequencing and Next-Generation Sequencing (NGS)
  • In Situ Hybridization (ISH)
  • DNA Microarrays
  • Others

By Application:

  • Infectious Disease Diagnostics
  • Oncology Testing
  • Genetic Testing
  • Others

By End User:

  • Diagnostic Laboratories
  • Hospitals and Clinics
  • Others

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Increased healthcare infrastructure, expansion of domestic companies, and inflating disposable incomes of the populace are some of the factors aiding the market expansion in the region. Furthermore, expanding geriatric population and rising incidences of infectious diseases, and higher adoption of molecular diagnostics in the Asia Pacific region is likely to boost further growth of the market through 2032.

Comments

Post a Comment

Popular posts from this blog

Mammography Market Demand, Scope and Future Estimation until 2032

  The global  mammography market    is estimated to be worth around  US$ 1.7 Billion  in 2022. However, with rising prevalence of breast cancer at an alarming rate the overall demand for mammography systems is anticipated to grow at around  6.5%  to  9% CAGR  between 2022 and 2032, totaling over  US$ 3.4 Billion  by 2032. Mammography  is a modern non-invasive medical imaging and diagnostic technique that uses low-dose X-rays to monitor breast tissues for the presence of tumor. It has become one of the most commonly used techniques for checking abnormalities in the absence of any symptoms. It has significantly aided in reducing breast cancer mortality rates worldwide. Increasing prevalence of breast cancer across the world along with growing awareness about the benefits of screening and early diagnosis of breast cancer is providing a major impetus to the growth of mammography market. It is one of the most common forms of cancer among females, worldwide. Various studies have found that t
Read more

Interventional Cardiology Devices Market Key Players, SWOT Analysis, Key Indicators & Forecast By 2032

  The  interventional cardiology devices market demand  is expected to grow at an  8.4%  CAGR from  USD 16.4  Billion in 2022 to USD  36.9  Billion by 2032. The fast expansion of the geriatric population and the corresponding increase in the prevalence of coronary artery diseases, the approval of new and sophisticated products, and the growing incidence of diabetes are all driving growth in the interventional cardiology devices market. However, the availability of alternative therapies, as well as product failures and recalls, are the primary factors projected to hinder interventional cardiology devices market growth over the projection period. COVID-19 has had a global influence on every element of the medical device business, including the market for interventional cardiology equipment. Despite the fact that emergency and outpatient treatments are offered in cardiology departments, the number of patient visits to hospitals has decreased dramatically in the last six months. Patient vi
Read more

Cardiac Rehabilitation Market Research, Segmentation, Key Players Analysis & Forecast By 2032

  The  cardiac rehabilitation market share  is likely to expand its roots in the global market at an average CAGR of 6.0% between 2022 and 2032. The market is valued at US$ 2.1 Bn in 2022 and is likely to reach US$ 3.8 Bn by 2032. Previously, the market was thriving at a slightly higher CAGR of 6.5% (2015-2021), ensuring a market size of US$ 2 Billion in 2021. “Growing lifestyle-related diseases like diabetes and cardiovascular strokes along with the technological revolution in the healthcare sector, helping the patients going through heart attack, heart valve surgeries, heart failures.” An unhealthy lifestyle is leading to new heart-related diseases like heart attacks and heart failure. The technologically advanced tools that enable easy surgery processes drive the sales of cardiac rehabilitation systems. These systems help end users with exercises, diet, stress management and training, managing and monitoring the daily progress of the health routine. It is largely consumed by The new
Read more